There are currently 1288 clinical trials in Cleveland, Ohio looking for participants to engage in research studies. Trials are conducted at various facilities, including Cleveland Clinic, Cleveland Clinic Foundation, Case Western Reserve University and University Hospitals Cleveland Medical Center. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
HA35 Moderate Alcoholic Hepatitis (AH) Study
NCT05018481
Recruiting
Eligible participants will be asked to take a placebo/treatment capsule for 90 days and participate in two in-person study visits, one at the start of the 90 days and the second at the completion of study supplement administration. Both visits will include a physical exam, clinical labs, body composition measurements, muscle strength tests, questionnaires, and urine and stool collections. Additionally, a sugar cocktail will be consumed to measure gut permeability and a muscle biopsy will be coll... Read More
Gender:
ALL
Ages:
Between 21 years and 65 years
Trial Updated:
01/08/2025
Locations: Cleveland Clinic, Cleveland, Ohio
Conditions: Alcoholic Hepatitis
Register for Updates
HA35 Acute Alcohol Study
NCT05025865
Recruiting
Eligible subjects will be asked to take a placebo/treatment capsule for a total of 3 days and then participate in a study visit on the fourth day. This study visit will include a medical exam, clinical labs, questionnaires, body composition measurements, and urine and stool collections. Additionally, participants will consume a sugar cocktail to measure their gut permeability, participate in an acute ethanol challenge, and undergo two muscle biopsies. The study will take approximately 3-4 hours... Read More
Gender:
ALL
Ages:
Between 21 years and 65 years
Trial Updated:
01/08/2025
Locations: Cleveland Clinic, Cleveland, Ohio
Conditions: Healthy Controls
Register for Updates
A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis
NCT06773195
Recruiting
The researchers are doing this study to find out whether the combination of ruxolitinib and ulixertinib is a safe and effective treatment for people with myelofibrosis. The researchers will test different doses of ulixertinib to find the highest dose that causes few or mild side effects in participants when given in combination with ruxolitinib.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/08/2025
Locations: Cleveland Clinic, Cleveland, Ohio
Conditions: Myelofibrosis
Register for Updates
Comparing Reduction With ESD- Versus APC-TORe
NCT06131281
Recruiting
The goal of this clinical trial is to compare two variations of the same procedure used to assist with weight loss in patients who have a history of Roux-en-Y gastric bypass who have experienced weight regain. The procedure being studied is called the Transoral Outlet Reduction (TORe), and the trial will compare two different ways to complete the TORe procedure. The main question\[s\] it aims to answer are: * Which variation of the TORe procedure results in more weight loss? * Which variation o... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/07/2025
Locations: Cleveland Clinic Foundation, Cleveland, Ohio
Conditions: Obesity, Roux-en-y Anastomosis Site, Weight Gain
Register for Updates
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
NCT06700460
Recruiting
Evaluating outcomes after bilateral implantation of ICLs or bilateral LASIK as treatment options for the correction or reduction of myopia with or without astigmatism.
Gender:
ALL
Ages:
Between 21 years and 45 years
Trial Updated:
01/07/2025
Locations: Cleveland Eye Clinic, Cleveland, Ohio
Conditions: Myopia
Register for Updates
OPEN Versus InTact Capsule Proton Pump Inhibitors for the Treatment of Marginal Ulcers
NCT05799105
Recruiting
The goal of this clinical trial is to identify the most effective way to take acid-blocking medications to treat stomach ulcers in patients who have undergone gastric bypass surgery. The main questions it aims to answer are: * is taking an acid-blocking medication by opening the capsule and only taking the contents of the capsule (open-capsule) more or less effective than taking the capsule as a whole (intact-capsule) for treating ulcers in patients who have a history of gastric bypass surgery?... Read More
Gender:
ALL
Ages:
All
Trial Updated:
01/07/2025
Locations: Cleveland Clinic Foundation, Cleveland, Ohio
Conditions: Marginal Ulcer
Register for Updates
Milk Thistle Clinical Trial in Pediatric NAFLD
NCT06477146
Recruiting
Pediatric Fatty Liver disease is a growing problem in the United States and is expected to be the leading cause of Liver Transplantation in Adults in 20 years. Following lifestyle changes such as diet restrictions and exercise may be difficult to consistently maintain. The purpose of this study is to investigate alternative medical therapy with an herbal supplement called Milk Thistle (MT) which may improve fatty liver disease and would be easier to follow than diet and exercise.
Gender:
ALL
Ages:
Between 9 years and 22 years
Trial Updated:
01/07/2025
Locations: University Hospitals Cleveland Medical Center, Cleveland, Ohio
Conditions: Non-Alcoholic Fatty Liver Disease (NAFLD)
Register for Updates
Patient Recall of Cancer Screening and Diagnosis
NCT05014295
Recruiting
The purpose of this research is to try to better understand how much information relating to cancer screening and diagnoses that people can recall on their own and to better understand how to help people get better information. In this study, investigators will see if giving time or other resources help individuals remember more and more accurate details about their cancer screening and care.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/06/2025
Locations: Case Comprehensive Cancer Center, Cleveland, Ohio
Conditions: Breast Cancer, Prostate Cancer
Register for Updates
A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease (IFALD).
NCT05919680
Recruiting
This is a phase 2a, multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of NST-6179 in subjects with intestinal failure-associated liver disease (IFALD) receiving parenteral nutrition (PN). The study will be conducted in 2 sequential parts. Up to 36 subjects diagnosed with IFALD will be enrolled in the study, of which up to 18 subjects will be enrolled in each of the 2 parts and randomized (2:1) t... Read More
Gender:
ALL
Ages:
16 years and above
Trial Updated:
01/05/2025
Locations: The Cleveland Clinic, Cleveland, Ohio
Conditions: Intestinal Failure Associated Liver Disease
Register for Updates
LUng voluMe reductIoN by DuAl ENergy CT Evaluation (LUMINANCE) Study
NCT05816239
Recruiting
The purpose of this research study is to see if a special CT scan (dual-energy CT) provides useful information in patients undergoing bronchsoscopic lung volume reduction (valve placement for emphysema). The investigators will enroll up to 30 participants in this study from University Hospitals Cleveland Medical Center. All of the participants from this study will undergo their valve procedure at University Hospitals Cleveland Medical Center.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
12/31/2024
Locations: University Hospitals Cleveland Medical Center, Cleveland, Ohio
Conditions: Lung Perfusion
Register for Updates
Accuracy of the Dexcom G7 Continuous Glucose Monitoring System Following Cardiac Surgery
NCT06338748
Recruiting
This is a prospective longitudinal study to study the agreement between a continuous glucose monitoring system (CGMS) versus current blood glucose monitoring. Subjects in this study will have their blood glucose measured regularly every 1-3 hours with current methods in the Cardiovascular Intensive Care Unit (CVICU), and by Point of Care (POC) fingerstick glucose using the Accucheck Inform II on the regular floors, and the CGMS reading at the same time will be captured. Subjects will have measur... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
12/30/2024
Locations: The Cleveland Clinic Foundation, Cleveland, Ohio
Conditions: Continuous Glucose Monitoring
Register for Updates
Detecting Mild Autonomous Cortisol Secretion in Patients With Adrenal Incidentaloma
NCT06344143
Recruiting
The aim of the proposed study is to estimate the incidence of Mild Autonomous Cortisol Secretion (MACS) in patients with Adrenal Incidentaloma (AI) and evaluate the available diagnostic tests to determine the most sensitive and specific combination of tests for assessing MACS from adrenal adenoma for prediction of the phenotype associated with cortisol excess. As well as following the patients for 4 years and see if anything changes.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
12/30/2024
Locations: The Cleveland Clinic Foundation, Cleveland, Ohio
Conditions: Mild Autonomous Cortisol Secretion (MACS)
Register for Updates